Response of refractory Kawasaki disease to pulse steroid and cyclosporin a therapy

Pediatric Infectious Disease Journal

Volumn 20, Issue 6, 2001, Pages 635-637

  Raman, Vidya ^b   Kim, Jennifer ^c   Sharkey, Angela ^a   Chatila, Talal ^b  

^a Divisions of Cardiology

^b Immunology and Rheumatology   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Coronary disease; Corticosteroids; Cyclosporin A; Kawasaki disease; Vasculitis

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG RESPONSE; HEART VALVE REGURGITATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PERICARDITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECURRENCE;

EID: 0034972003     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200106000-00022     Document Type: Article

References (10)

1. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
2. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease: US/Canadian Kawasaki Syndrome Study Group
3. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
4. Kawasaki disease: A "new" pediatric enigma
5. Kawasaki disease: Canadian update
6. Complement and protease inhibitors in the mucocutaneous lymph node syndrome
7. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon
8. Kawasaki disease: Effect of treatment on coronary artery involvement
9. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease
10. Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis